SHR - A1811 Injection in the Treatment of Platinum-sensitive Recurrent Ovarian Cancer
Clinical trial NCT06990516 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06990516
- Sponsor
- Tongji Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2030-06-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.